La linfadenectomia retroperitoneal monolaterale laparoscopica nelle neoplasie non seminomatose del testicolo in stadio clinico I

Translated title of the contribution: Unilateral laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous testicular cancer

P. Beltrami, G. Giusti, C. Tallarigo, A. Mofferdin, G. Mobilio

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Since June 1993, unilateral laparoscopic retroperitoneal lymph node dissection (LRPLND) was performed in 6 patients diagnosed with clinical stage I nonseminomatous germ cell tumors (NSGCT). All of the patients had undergone prior radical orchiectomy. The testicular cancer was left-sided in three cases and right-sided in three cases. Preoperative staging by means of tumor markers assessment, computerized tomography scan (CT) of the chest and abdomen and chest X-ray was unremarkable for metastatic disease. All procedures were accomplished without any complications in a mean time of 325 min (275 to 420 min). The estimated peri- and postoperative blood loss was minimal. Of note, the comparison between the hematocrit and hemoglobine decrease of LRPLND and RPLND showed a statistically significant reduction (3.1 vs 11.1% P <0.01 and 1.1 vs 3.2 g/dl P <0.01). None of the patients required blood transfusion. In the case of the first patient the hospital stay was 18 days due to a widespread subcutaneous emphysema. In the remaining five cases the average hospitalization was 4.8 days ranging between 4 and 6 days. The patients resumed normal activities within 12 to 27 days (mean 16.2 days) postoperatively. Mean number of lymph nodes removed was 6.8, ranging between 5 and 9. Histologic examination of the dissected lymph nodes revealed microscopic metastases from embryonal carcinoma in two patients. Both of these patients were subject to adjuvant chemotherapy. The mean follow-up period is 33.3 months, ranging between 18 and 48 months. To date, no relapses have been observed. In accordance with other reports, we believe that LRPLND is both feasible and effective. However, larger and more comprehensive studies with long-term follow-up are required to determine whether this approach is reliable and definitely superior to standard open surgery in the management of clinical stage I NSGCT.

Original languageItalian
Pages (from-to)27-35
Number of pages9
JournalArchivio Italiano di Urologia e Andrologia
Volume70
Issue number1
Publication statusPublished - 1998

Fingerprint

Testicular Neoplasms
Lymph Node Excision
Thorax
Lymph Nodes
Embryonal Carcinoma
Subcutaneous Emphysema
Postoperative Hemorrhage
Orchiectomy
Adjuvant Chemotherapy
Tumor Biomarkers
Hematocrit
Blood Transfusion
Abdomen
Length of Stay
Hospitalization
Tomography
X-Rays
Neoplasm Metastasis
Recurrence

ASJC Scopus subject areas

  • Nephrology
  • Urology

Cite this

La linfadenectomia retroperitoneal monolaterale laparoscopica nelle neoplasie non seminomatose del testicolo in stadio clinico I. / Beltrami, P.; Giusti, G.; Tallarigo, C.; Mofferdin, A.; Mobilio, G.

In: Archivio Italiano di Urologia e Andrologia, Vol. 70, No. 1, 1998, p. 27-35.

Research output: Contribution to journalArticle

Beltrami, P. ; Giusti, G. ; Tallarigo, C. ; Mofferdin, A. ; Mobilio, G. / La linfadenectomia retroperitoneal monolaterale laparoscopica nelle neoplasie non seminomatose del testicolo in stadio clinico I. In: Archivio Italiano di Urologia e Andrologia. 1998 ; Vol. 70, No. 1. pp. 27-35.
@article{daf8b19e541d4d9b9e51799dba7d5678,
title = "La linfadenectomia retroperitoneal monolaterale laparoscopica nelle neoplasie non seminomatose del testicolo in stadio clinico I",
abstract = "Since June 1993, unilateral laparoscopic retroperitoneal lymph node dissection (LRPLND) was performed in 6 patients diagnosed with clinical stage I nonseminomatous germ cell tumors (NSGCT). All of the patients had undergone prior radical orchiectomy. The testicular cancer was left-sided in three cases and right-sided in three cases. Preoperative staging by means of tumor markers assessment, computerized tomography scan (CT) of the chest and abdomen and chest X-ray was unremarkable for metastatic disease. All procedures were accomplished without any complications in a mean time of 325 min (275 to 420 min). The estimated peri- and postoperative blood loss was minimal. Of note, the comparison between the hematocrit and hemoglobine decrease of LRPLND and RPLND showed a statistically significant reduction (3.1 vs 11.1{\%} P <0.01 and 1.1 vs 3.2 g/dl P <0.01). None of the patients required blood transfusion. In the case of the first patient the hospital stay was 18 days due to a widespread subcutaneous emphysema. In the remaining five cases the average hospitalization was 4.8 days ranging between 4 and 6 days. The patients resumed normal activities within 12 to 27 days (mean 16.2 days) postoperatively. Mean number of lymph nodes removed was 6.8, ranging between 5 and 9. Histologic examination of the dissected lymph nodes revealed microscopic metastases from embryonal carcinoma in two patients. Both of these patients were subject to adjuvant chemotherapy. The mean follow-up period is 33.3 months, ranging between 18 and 48 months. To date, no relapses have been observed. In accordance with other reports, we believe that LRPLND is both feasible and effective. However, larger and more comprehensive studies with long-term follow-up are required to determine whether this approach is reliable and definitely superior to standard open surgery in the management of clinical stage I NSGCT.",
keywords = "Laparoscopy, Retroperitoneal lymph node dissection, Testicular neoplasm",
author = "P. Beltrami and G. Giusti and C. Tallarigo and A. Mofferdin and G. Mobilio",
year = "1998",
language = "Italian",
volume = "70",
pages = "27--35",
journal = "Archivio Italiano di Urologia Nefrologia Andrologia",
issn = "1120-8538",
publisher = "Edizioni Scripta Manent s.n.c.",
number = "1",

}

TY - JOUR

T1 - La linfadenectomia retroperitoneal monolaterale laparoscopica nelle neoplasie non seminomatose del testicolo in stadio clinico I

AU - Beltrami, P.

AU - Giusti, G.

AU - Tallarigo, C.

AU - Mofferdin, A.

AU - Mobilio, G.

PY - 1998

Y1 - 1998

N2 - Since June 1993, unilateral laparoscopic retroperitoneal lymph node dissection (LRPLND) was performed in 6 patients diagnosed with clinical stage I nonseminomatous germ cell tumors (NSGCT). All of the patients had undergone prior radical orchiectomy. The testicular cancer was left-sided in three cases and right-sided in three cases. Preoperative staging by means of tumor markers assessment, computerized tomography scan (CT) of the chest and abdomen and chest X-ray was unremarkable for metastatic disease. All procedures were accomplished without any complications in a mean time of 325 min (275 to 420 min). The estimated peri- and postoperative blood loss was minimal. Of note, the comparison between the hematocrit and hemoglobine decrease of LRPLND and RPLND showed a statistically significant reduction (3.1 vs 11.1% P <0.01 and 1.1 vs 3.2 g/dl P <0.01). None of the patients required blood transfusion. In the case of the first patient the hospital stay was 18 days due to a widespread subcutaneous emphysema. In the remaining five cases the average hospitalization was 4.8 days ranging between 4 and 6 days. The patients resumed normal activities within 12 to 27 days (mean 16.2 days) postoperatively. Mean number of lymph nodes removed was 6.8, ranging between 5 and 9. Histologic examination of the dissected lymph nodes revealed microscopic metastases from embryonal carcinoma in two patients. Both of these patients were subject to adjuvant chemotherapy. The mean follow-up period is 33.3 months, ranging between 18 and 48 months. To date, no relapses have been observed. In accordance with other reports, we believe that LRPLND is both feasible and effective. However, larger and more comprehensive studies with long-term follow-up are required to determine whether this approach is reliable and definitely superior to standard open surgery in the management of clinical stage I NSGCT.

AB - Since June 1993, unilateral laparoscopic retroperitoneal lymph node dissection (LRPLND) was performed in 6 patients diagnosed with clinical stage I nonseminomatous germ cell tumors (NSGCT). All of the patients had undergone prior radical orchiectomy. The testicular cancer was left-sided in three cases and right-sided in three cases. Preoperative staging by means of tumor markers assessment, computerized tomography scan (CT) of the chest and abdomen and chest X-ray was unremarkable for metastatic disease. All procedures were accomplished without any complications in a mean time of 325 min (275 to 420 min). The estimated peri- and postoperative blood loss was minimal. Of note, the comparison between the hematocrit and hemoglobine decrease of LRPLND and RPLND showed a statistically significant reduction (3.1 vs 11.1% P <0.01 and 1.1 vs 3.2 g/dl P <0.01). None of the patients required blood transfusion. In the case of the first patient the hospital stay was 18 days due to a widespread subcutaneous emphysema. In the remaining five cases the average hospitalization was 4.8 days ranging between 4 and 6 days. The patients resumed normal activities within 12 to 27 days (mean 16.2 days) postoperatively. Mean number of lymph nodes removed was 6.8, ranging between 5 and 9. Histologic examination of the dissected lymph nodes revealed microscopic metastases from embryonal carcinoma in two patients. Both of these patients were subject to adjuvant chemotherapy. The mean follow-up period is 33.3 months, ranging between 18 and 48 months. To date, no relapses have been observed. In accordance with other reports, we believe that LRPLND is both feasible and effective. However, larger and more comprehensive studies with long-term follow-up are required to determine whether this approach is reliable and definitely superior to standard open surgery in the management of clinical stage I NSGCT.

KW - Laparoscopy

KW - Retroperitoneal lymph node dissection

KW - Testicular neoplasm

UR - http://www.scopus.com/inward/record.url?scp=0031594453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031594453&partnerID=8YFLogxK

M3 - Articolo

C2 - 9549166

AN - SCOPUS:0031594453

VL - 70

SP - 27

EP - 35

JO - Archivio Italiano di Urologia Nefrologia Andrologia

JF - Archivio Italiano di Urologia Nefrologia Andrologia

SN - 1120-8538

IS - 1

ER -